A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes (T2D). The study will last around 31 weeks.
Inclusion Criteria:
Have a body mass index (BMI) ≥27 kilogram/square meter (kg/m²)
Have either
Have been diagnosed with chronic kidney disease (CKD).
Exclusion Criteria:
Chandler, Arizona 85225, United States
North York, Ontario M6B 3H7, Canada